Udaya Rangaswamy | Director of Translational Biology
Rondo Therapeutics | United States

Udaya Rangaswamy, Director of Translational Biology, Rondo Therapeutics

Udaya Rangaswamy is Director of translational biology at Rondo therapeutics, a start-up focused on novel multi-specific engagers for solid tumors. Prior to Rondo, Udaya was a Principal Scientist at Amgen following Amgen’s acquisition of Teneobio in 2021. Between both Amgen and Teneobio, Udaya has supported development of CD3-based bispecific antibodies from lead optimization through first-in-human studies, including three programs currently active in the clinic. Prior to Teneobio, Udaya was a post-doc at MedImmune/Astrazeneca working on an oncolytic virus platform. Udaya received her PhD in microbiology and molecular genetics from Emory University and her thesis work identified novel signaling pathways driving the pathogenesis of an oncogenic viral protein.

back to speakers

Get involved at Festival of Biologics USA 2026

 

 

TO SPONSOR


Nicholas Matthews

Nicholas.Matthews@terrapinn.com

 

Rosalind Corrie
Rosalind.corrie@terrapinn.com

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

ollie.mcdaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.